Reglan Receives Black Box Warning for Tardive Dyskinesia

January 14, 2017

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Patients who have taken Reglan or metoclopramide and developed tardive dyskinesia.
Damages
Some Reglan users have developed the neurological disorder tardive dyskinesia which causes rapid eye blinking, lip smacking, lip puckering and involuntary movement of the fingers, hands, arms and legs. Patients with tardive dyskinesia may also experience difficulty walking, talking, breathing and swallowing.
Companies
Baxter Pharmaceutical and Schwarz Pharma Inc.
Additional Details
Reglan and other metoclopramide-containing drugs are prescribed to treat gastrointestinal disorders including acid reflux disease, gastroesophageal reflux disease (GERD) and diabetic gastroparesis. Metoclopramide may also be prescribed to treat nausea and vomiting related to chemotherapy or post-operative side effects.
Date
Reglan and metoclopramide-containing drugs have not been recalled, but received a black box warning in February 2009.